SeaStar Medical Holding Corporation Share Price
ICUSeaStar Medical Holding Corporation Stock Performance
Open $4.12 | Prev. Close $4.21 | Circuit Range N/A |
Day Range $4.09 - $4.12 | Year Range $0.22 - $4.87 | Volume 229 |
Average Traded $4.11 |
SeaStar Medical Holding Corporation Share Price Chart
About SeaStar Medical Holding Corporation
SeaStar Medical Holding Corporation, a commercial-stage medical device company, develops a proprietary platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers the selective cytopheretic device (SCD), which is a disease-modifying device that neutralizes over-active immune cells and stops the cytokine storm that yields destructive hyperinflammation; and QUELIMMUNE, an SCD therapy for pediatric patients with acute kidney injury (AKI) due to sepsis. It also develops NEUTRALIZE-AKI, an SCD therapy that is in clinical trials for adult patients with AKI; and other products in various therapeutic areas, including cardiorenal syndrome, hepatorenal syndrome, and myocardial stunning in end-stage renal disease. SeaStar Medical Holding Corporation was founded in 2007 and is headquartered in Denver, Colorado.
SeaStar Medical Holding Corporation Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
07-Apr-26 | $4.33 | $4.14 | -9.21% |
06-Apr-26 | $4.30 | $4.56 | +4.11% |
02-Apr-26 | $3.58 | $4.38 | +23.03% |
01-Apr-26 | $3.55 | $3.56 | -5.82% |
31-Mar-26 | $3.94 | $3.78 | +5.29% |
30-Mar-26 | $3.17 | $3.59 | +31.99% |
27-Mar-26 | $2.78 | $2.72 | -2.86% |